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We have previously shown that cellular retinoic acid-
binding protein II (CRABP-II), but not cellular retinoic 
acid - binding protein I (CRABP-I), mRNA expression is 
markedly induced in human skin by topical retinoic acid. In 
the present study, we have investigated the pattern of expres-
sion of CRABP-II transcripts in 4-d RA-treated human skin 
by non-radioactive in situ hybridization (n = 5) and North-
ern analysis (n = 4). RA induced accumulation of CRABP-II 
transcripts throughout the epidermis, dermal fibroblasts, and 
endothelial cells as determined by in situ hybridization. In 
skin treated with vehicle, a faint hybridization signal was 
observed only in basal layers of the epidermis consistent with 
low-level expression of CRABP-II mRNA. RA-mediated 
accumulation of CRABP-II transcripts in skin was also c~n­
firmed by Northern analysis . Neither RA nor vehicle tn-
duced significant changes in nuclear RA receptor-yl or kera-
tin 5 gene expression in skin as determined by in situ . or 
Northern hybridization. These results indicate that RA-tn-
duced CRABP-II mRNA accumulation is primarily localiz~d 
to spinous and granular layers in epidermis, and in superficial 
dermis. ] Invest Dermatol 99:146 -150, 1992 
---------------------------------------------------------------------------------------------------------
R etinoic acid (RA), a vitamin A derivative, is essential for epithelial cell organization and function [1,2]. RA interacts with two families of intracellular binding proteins. One class of binding protein includes the nuclear retinoic acid receftor (RAR) family, which is 
composed of RAR-a, -p, and -y [3 - 6 . At least seven isoforms of 
RAR-y have been identified, of which RAR-y1 mRNA appears to 
be the rredominant RAR-y isoform expressed at high levels in 
mouse [7] and human skin [8]. RA also interacts with a family of 
low -molecular-weight cytosolic binding proteins known as cellu-
lar retinoic acid - binding proteins (CRABP) [9,10]. CRABP pro-
tein levels are elevated in psoriatic lesions and in retinoid-treated 
skin [8,11,12] in vivo, suggesting that it may playa role in mediat-
ing cutaneous retinoid effects. 
To better understand the effects of RA in human skin, we have 
recently cloned eDNA for both human CRABP-I and CRABP-II 
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Abbreviations: 
CRABP: cellular retinoic acid-binding protein 
DIG: digoxigenin 
eDNA: complementary deoxyribonucleic acid 
EC: endothelial ce lls 
FB: fibroblasts 
mRNA: messenger ribonucleic acid 
PCR: polymerase chain reaction 
PFA: paraformaldehyde 
RA: retinoic acid 
RAR-)'l: nuclear retinoic acid receptor-),l 
RNAse A: ribonuclease A 
UTP: uridine triphosphate 
[13]. Using Northern analysis, we previously demonstrated thaJ 
topical application of 0.1 % RA cream for 4 d produced marke 
induction of CRABP-I1 but not CRABP-I transcripts in keratome 
specimens in vivo [8]. . 
Recently, a sensitive, non-radioactive in situ hybridizatiOn 
method based on the use of digoxigenin-11-UTP analog has been 
developed for localization of specific RNA transcripts [14]. By eX-
amining expression of several messenger RNA, we have derno~­
strated that this method is useful for detection of RNA transcripts In 
human skin. Using this technique, we report here the cell and tissue 
localization of CRABP-II, RAR-y1, and keratin 5 transcripts !O 
human skin following 4-d topical application of RA. 
MATERIALS AND METHODS 
Tissue Preparation Healthy human volunteers were treated on 
separate areas of the buttocks (9 X 3 em) with a single dose of ap-
proximately 500 mg 0.1 % RA cream (Retin A) or its vehicle (Orthd Pharmaceutical Corp. , Raritan, NJ) which were maintained for ~ 
under occlusion prior to biopsy [13]. After obtaining written !II-
formed consent, keratome biopsies and 4-mm punch biopsies were 
procured from the treated areas using 1 % lidocaine as a local anes-
thetic as previously described [15]. All protocols for human subj~ctS 
were approved by the University of Michigan Institutional Revle~ 
Board. For in situ hybridization, full-thickness biopsies (n "'" d 
were obtained by 4-mm punch, fixed in 4% paraformaldehY e 
(PFA) in 0.1 M sodium phosphate, pH 7.4, for 2 h, and cryopro' 
tected in 30% sucrose solution for at least 3 h. The fixed tissue was 
embedded in OCT (Lab-Tek, Naperville, IL) , sectioned at 5 J.l~ 
onto poly-L-lysine coated slides, and stored at -70°C. For North 
ern analyses, 0.2-mm-thick epidermal keratomes (n = 4) were 
snap-frozen in liquid nitrogen and stored until use. 
eDNA Cloning, Plasmid Preparation, and Northern Analy' 
sis The human CRABP-II eDNA was isolated by polyrnerase 
chain reaction (PCR) amplification directly from human skin uSing 
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two degenerate oligonucleotide primers to the deduced amino acid 
sequences 6 to 130 of mouse CRABP-II [10] . 
Forward primer: 
51-CAT CGG ATC CCA ACT GGA AGA TCA TCC GA-3' 




5'-CAT CGG' ATC CCA ACG TCA TCT GCT GTC ATT-3' 
TAG A A 
C C C 
G G G 
I The 373-bp PCR fragment corresponding to CRABP-II was 
coned mto pGEM3Z plasmid (Promega Inc., Madison WI), se-
~uenced, and found to be identical to the previously published 
w~tnan .CRABP-II sequence [13]. Isoform-specific RAR-yl probe 
b s a gift from professor Pierre Chambon, CNRS-LGME, Stras-
R;~g, that was generated by subcloning of nucleotides 25 - 586 of 
k' d -y1 sequence [7]. The cDNA clone for keratin 5 (K5) was a t gift from Dr. Elaine Fuchs, University of Chicago. Identities 
o dDNA probes were confirmed by enzyme restriction mapping 
~~ DNA sequencing. Plasmid DNA synthesis, probe labeling, 
.t preparation, and Northern analysis have been previously de-
Sh\ed [13]. Blots were later hybridized to the control gene cyclo-
p I ~n [16] to ensure equal RNA loading (results not shown). The 
~te~ y-state mRNA levels for this gene have been previously shown 
o e unaffected by topical RA application in human skin [8,13]. 
!n Vitro Transcription of cRNA Probes Transcripts were gen-
;.ate~ usi.ng the Genius RNA labeling kit (Boehringer Mannheim 
dIOC ~mlcals, Indianapolis, IN) and a modified uracil nucleotide, 
3~g30blgenin-11-UTP (DIG). The pGEM3Z plasmid containing 
E R p of human CRABP-II cDNA was linearized with HindIII or 
o c~p I and antisense or sense riboprobes were synthesized with T7 
P r b 6 polymerase, respectively. RAR-yl antisense and sense ribo-
s:o es Were prepared by T7 and T3 polymerases from the Blue-
o rlt vector (Stratagene, La Jolla, CAl, linearized with either Sac! 
a; d cbRI, respectively. Antisense and sense K5 probes were gener-
s/ h YEco~I and HindIII digestion of plasmid followed by RNA 
tr nt e~ls wuh eitherT7 or SP6, respectively. DIG-labeled K5 RNA 
n~~scnpts were partially hydrolyzed to generate 250 - 500-
iz c. eotlde long probes [17] for Western analysis and in situ hybrid-
atlon. 
W 
I'U estern Blotting of RNA Probes The relative efficiencies of corp . d
et oration of DIG analog by all three RNA polymerases were RN~tnmed for each riboprobe. Sense and antisense DIG-labeled 
llJald hrobes (20 - 25 ng) were size-fractionated on denaturing for-
(Ivl' e yde gels and transferred to Magnagraph nylon membranes 
thelcr~n Separations Inc., Westboro, MA). Western blotting of 
durse dIG-labeled riboprobes was carried out following the proce-
che es. escnbed by the manufacturer (Boehringer Mannheim Bio-
tnlcals, Reagents for Molecular Biology 1991, p 114). 
In Situ Hyb 'd' , I' h b 'd" h . sillJil
ar 
rt lzat~on n ~Itu y n IzatlOn tec. mques were 
tion to those descnbed preVIOusly [14,17]' With slight modlfica-
Tech as described in the Boehringer Mannheim Biochemicals 
5 1lJ' nlcal Bulletin. Briefly, slides were transferred into PBS for 
MDr and incubated with proteinase K (Gibco BRL, Gaithersburg, 
PBS ~/ flg(ml for 10 min.at 37"C. Se~tions were then washed in 
rinsed i 5 mm, post-fixed m PAF/sodlUm phos.phate buffer, and 
diullJ n 2 >:< SSC (1 X SSC = 0.15 M sodIUm Citrate, 15 mM so-
forllJ dC~londe), Prehybridization and hybridization were per-
0.25 ~ I/n a buffer containing 50% deionized formamide, 4 X SSC, 
DNA t tnl yeast tRNA, 0.5 mg/ml heat-denatured salmon sperm 
0.5_i >< Denhardt's, 10% dextran sulfate heated to 60°C, and 
slides flg/~l of DIG-labeled cRNA probe in 30 f1l volume. The 
tions :ere I11cubated at 42 ° C overnight. After hybridization, sec-
final 0 ~rX washed in two changes of2 X SSC for 1 h, followed by a 
. SSC wash for 20 min at room temperature. The non-
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Figure 1. Autoradiograms of RNA blots derived from keratome biopsies 
are shown. Total RNA (30 J1.g per lane) was hybridized against the cDNA 
probes for CRABP-II (A), RAR-yl (B), and K5 (C). A plus sign denotes 
RA-treated skin, w hereas a mi,ws sign indicates skin treated with vehicle 
alone. Mobilities of ribosomal RNA are shown at the left. All blots were 
hybridized to a cyclophilin control gene and showed insignificant loading 
differences (results not shown). 
hybridized excess cRNA probe was removed by incubation of the 
sections with 200 f1g/ml ribonuclease A (RNase A) for 10 min at 
37"C. 
Immunohistochemical Detection RNA hybrids were de-
tected by a procedure similar to that described by the manufacturer 
(Boehringer Mannheim Biochemicals), with some modification. 
Briefly, slides incubated with DIG-labeled probes were rinsed at 
room temperature in 100 mM Tris-HCI, pH 7.4,150 mM NaCL, 
0.2% T~een-20 (TNE) for 5 min. Anti-DIG antibody coupled to 
horseradish peroXidase at 3 - 7 U / ml was added and slides were 
incu~ated in a h';lmid chamber f?r 45 min at 37"C, followed by 
addition of peroXidase substrate, 3 -amino-9-ethylcarbazole, 0.05% 
wt/vol in acetate buffer, and H 20 2 at a final concentration of 
0.01 % . . The chro~ogenic reaction was stopped by rinsing in PBS 
for 5 mm. The shdes were then mounted and viewed by light mi-
croscopy. 
Control Experiments Several controls were included to moni-
tor the specificity of reactions. For non-specific hybridization to 
mRNA, epidermal sections were pretreated with RNase A (200 
f1g/ml) for 20 min at 37"C and then processed as described above. 
In some experiments, the DIG-labeled probes or anti-DIG antibod-
ies were omitted to rule out non-specific staining. Finally, sense 
nboprobes for C~P-II, RAR-yl, and K5 were separately hybrid-
Ized to several sectIOns to ascertain probe specificity and background 
hybridization. 
RESULTS 
Modulation of CRABP-II, RAR-y1, and K5 Gene Expression 
in RA-Treated Skin To examine the effects of RA on gene 
expression at the mRNA level, [32P]-labeled CRABP-II, RAR-yl, 
and K5 probes were hybridized to Northern blots ofRA and vehi-
cle-treated skin (n = 4). Four-day treatment of skin with RA but not 
vehicle cream, under occlusion, resulted in a substantial induction of 
1.3.-kb CRABP-II mRNA levels (Fig lA). In contrast, topical appli-
c.atlOn of RA did not affect RAR-yl or K5 mRNA expression rela-
tive to the vehicle control (Fig IB, C). The size of mRNA for 
~R-yl and ~5 in skin wa~ estimated at 3.3 and 2.3 kb, respec-
tively, compatl.ble With ~rev~ously published work [7,8,18]. 
Pnor t.o l~ Situ hybndlzatlon,. the incorporation of DIG analog 
and speCifiCity of anti-DIG antibodies for the RNA probes were 
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Figure 2. Western analysis. Comparative efficiency of DIG analog incorpo-
ration into antisense (AS) and sense (S) riboprobes synthesized by RNA 
polymerase. After RNA blotting (15 - 25 ng per lane), the transcripts were 
immunodetected by anti-DIG antibodies as described in Materials alld Meth-
ods. The size of RNA transcripts are approximately 400 nucleotides for 
CRABP-II (A), 600 nucleotides for RAR-)'1 (B), 200- 500 nucleotides for 
K5 (C), and 760 nucleotides for the RNA marker, BMB (D). Note that for 
each riboprobe, both sense and antisense cRN A are of identical size as indi-
cated by arrows. 
confirmed by W estern blotting of RNA transcripts. Incubation of 
anti-DIG antibodies with filters containing both sense and antisense 
riboprobes, followed by the addition of peroxidase substrate, re-
sulted in detection of single RNA bands ranging from a pink to light 
red color caused by the chromogenic reaction (Fig 2A - D). Regard-
less of orientation of RNA synthesis, antisense and sense RNA tran-
scripts for both CRABP-II and RAR-yl were intact as determined 
by their identical size on agarose gels (Fig 2A, B) . Moreover, com-
parison of the size of these cRNA probes with the known size of a 
control RNA marker supplied by the Boehringer Mannheim Bio-
chemicals (BMB in Fig 2D) indicated that the use of DIG-modified 
nucleotides in in vitro transcription assays did not cause premature 
chain termination of riboprobes. Prior to gel electrophoresis, the K5 
cRNA probe shown in Fig 2C was hydrolyzed to produce probes of 
200 - 600 nucleotides [17] and thus it appears as a smear on gels. 
Cell and Tissue Localization ofKS, RAR-y1, and CRABP-II 
Transcripts We first examined the distribution of K5 mRNA in 
skin by in situ hybridization before proceeding with those mRNA 
whose location in RA-treated human skin had not been previously 
determined . Using the K5 antisense riboprobe, a strong signal was 
detected in both 4-d vehicle and RA-treated epidermal sections 
(n = 5), which was localized predominantly to basal cells (Fig 3A, 
B), consistent with a previous report [18] . Pretreatment of epider-
mal sections with RNase A (Fig 3C) or hybridization of sections 
with the sense riboprobe (Fig 3D) markedly diminished the K5 
hybridization signal. 
In vehicle-treated skin, CRABP-II mRNA was not induced, al-
though a faint hybridization signal was seen in basal layers of epider-
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mis (Fig 4A). In contrast, 4 d of RA treatment greatly increased 
CRAEP-II transcripts, particularly in basal and suprabasal layers 
(Fig 4B). In RA-treated skin, intracellular staining was observed 
throughout epidermis with a clear distribution of signals towards 
the upper pole of keratinocytes. Hybridization signal was also de-
tected in some but not all nuclei of cells. Of particular interest was 
the extensive staining and localization of CRAEP-II RNA tran-
scripts in spinous and granular layers in RA as compared to vehicle-
treated skin (arrowheads in Fig 4A, B). Specificity of reactions was 
demonstrated by pretreatment with RNase A intended to degrade 
endogenous skin mRNA, and hybridization of RA-treated epider-
mal sections with CRAEP-II sense probe. These controls were nega-
tive in all instances and produced minimal background (Fig 4C, D). 
Increased CRAEP-II transcripts were also observed as strong hybrid-
ization signal in superficial dermis within endothelial cells and cells 
with fibroblast-like morphology (Fig 4B). Examination of these 
sections by light microscopy under higher magnification revealed 
that hybridization signals were localized to spindle-shaped fibr~­
blasts (magnification X 250, Fig SA) and endothelial cells (magni-
fication X 100, Fig 5B). 
In situ hybridization with the RAR-yl antisense probe revealed a 
uniform distribution of mRNA transcripts in epidermis. In vehicle-
treated skin, hybridization signal was mainly cytoplasmic in epider-
mal and dermal cells (Fig 6A). An analogous pattern of expreSSIOn 
was also observed in RA-treated skin (Fig 6B) with no signific~nt 
differences in signal intensity between RA and vehicle-treated skin. 
As before, hybridization of RNase pretreated sections with the anti-
sense probe, or the use of a sense RAR-yl probe, exhibited no sign~fi­
cant staining (Fig 6C, D), demonstrating the specificity of in SitU 
hybridization. 
DISCUSSION 
Previous work has shown that total CRAEP activity in skin is in-
duced by both topical and systemic administration of natural and 
synthetic retinoids [12,19]. By cloning cDNA for two hurn~n 
CRABP isoforms, CRAEP-I and CRAEP-II and Northern analYSIS, 
we have recently demonstrated that CRAEP-II, but not CRABP-I 
transcripts, are markedly induced by topical RA treatment in whole 
keratome biopsies in vivo [13]. In this report, we have extended ?ur 
findings by examining the pattern of CRAEP-II mRNA expreSSion 
in RA-treated skin using non-radioactive in situ hybridization. I 
We have preVIOusly reported that although epidermal CRABP-I 
mRNA is markedly elevated by RA in vivo, it is not induced In 
B 
f t t t 
Figure 3. Localization of keratin 5 transcripts in basal keratinocytes jns(~). 
(magnification X 37.5) treated with RA vehicle (A), or RA 0.1 % cream " 
Also shown are hybridization of skin previously treated with ribonucleas\e 
against K5 antisense probe (C) and a section hybridized to a sense nbopro 
(D). 




Figure 4. Pattern of expression of CRABP-JI mRNA in human skin 
lrnanglfication X 37 .5} treated with RA vehicle (A) or RA 0.1 % cream (B). 
n RA cornpared to vehicle-treated skin, hybridization signal is increased and 
extends into spinous and granular layers (indicated by arrowheads). In RA-
tre~ted skin, signal is also visible in cells with fibroblast-like morphology and 
eb othelial cells in superficial dermis. The controls are characterized by a ~ence of staining in vehicle-treated skin preincubated with ribonuclease A h\ probed with antisense CRABP-II riboprobe (C), or RA-treated ski;! 




F' d~~~re S. Expression of CRABP-JI transcripts in human dermal cells. In-
in R:: of CRABP-JI transcripts was observed by in situ hybridization only 
rnagn'fi-treated skin and localized within dermis to fibroblasts (A, 
Cells sll cation X 250), and endothelial cells (magnification X 100, B). The 
lOWing hybridization signal have been indicated by arrows. 




Figure 6. Localization of RAR-yl transcripts in epidermal keratinocytes 
and dermal cells in vehicle-treated (A), or RA-treated skin (B). Diffuse 
cytoplasmic signal is visible in epidermal keratinocytes hybridized against 
RAR-yl probe. Also shown are sections treated with RNase prior to hybrid-
ization with an antisense probe (C), or hybridized with the sense RAR-yl 
(D) . Note that these procedures abrogate the staining reaction. 
Magnification X 37.5. 
monolayer cultures of human keratinocytes in vitro [13]. In situ 
hybridization reveals that the increased CRABP-Il mRNA seen in 
whole epidermal biopsies [13] is derived not only from keratino-
cytes in the epidermis, but also from dermal fibroblasts as well as 
endothelial cells in superficial dermis. Thus, these findings imply 
that a stratified epidermis and/or the presence of dermis may be 
important determinants for induction of CRABP-Il mRNA expres-
sion by RA in skin in vivo. CRABP-I mRNA is normally undetect-
able in normal adult human skin, as has been recently shown by in 
situ hybridization [20] and Northern analysis [8], and it is not in-
creased by RA in skin as we have previously demonstrated [13]. 
Thus, the upregulation of CRABP-Il transcripts by RA seen here is 
independent and unrelated to changes in CRABP-I mRNA levels. 
Moreover, the faint hybridization signal observed by in situ hybrid-
ization in basal keratinocytes in vehicle-treated skin is presumably 
the result of low level presence of CRABP-Il mRNA, consistent 
with our Northern analysis. These results are compatible with the 
recent findings that increased CRABP-Il, but not CRABP-I tran-
scripts, are responsible also for elevated CRABP mRNA levels in 
psoriatic skin [8,20] . 
The marked increased in hybridization signal in cells in spinous 
and granular layers of epidermis in response to RA indicates an 
increase in steady-state CRABP-I1 mRNA levels in differentiated 
keratinocytes. If an elevated mRNA level reflects a relative increase 
in functional protein expression, one can speculate that CRABP-I1 
is an active participant in the cellular response to RA in human skin. 
In F9 teratocarcinoma cells, overexpression of CRABP-I appears to 
limit the differentiating effects of RA [21]. It remains to be deter-
mined whether or not induction of CRABP-I1 mRNA by RA in 
spinous and granular layers, as demonstrated by in situ hybridiza-
tion, serves a similar purpose. 
No significant changes in RAR-y1 transcript levels were seen in 
either RA or vehicle-treated skin by in situ hybridization or North-
ern analysis. Because previous Northern analyses have also demon-
strated insignificant changes in RAR-y1 mRNA levels in skin in 
response to RA [8], our current in situ data provide additional sup-
port that RAR-y1 mRNA is not increased by RA in skin. Presence of 
predominantly cytoplasmic staining for RAR-y1 may reflect the 
steady-state transcript levels and argue against a high rate of RAR-
yl mRNA turnover. Our in situ studies further indicate that RA, 
when applied topically does not alter the pattern of expression ofKS 
mRNA in human skin. Keratin S and keratin 14 are two keratin 
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pairs whose mRNA are coordinately regulated and uniquely ex-
pressed in basal cells in normal skin [1 8]. These results are consistent 
with a previous report that RA does not alter basal cell expression of 
immunostained keratin 14 in vivo [22]. 
In conclusion, we have utilized a digoxigenin-labeled CRABP-II 
riboprobe to study cell and tissue expression of CRABP-II mRNA 
in 4-d RA-treated human skin. We have demonstrated that 
CRABP-II transcripts accumulated in the epidermis and superficial 
dermis in response to RA. No significant changes occurred in either 
RAR-y1 or keratin 5 mRNA levels as determined by in situ hybrid-
ization and Northern analysis. 
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